Natco Pharma Limited is a health sector company whose main business is drug manufacturing. This company is known for manufacturing various types of medicines.
Started in 1981 in Hyderabad with just 3.3 million INR, this company is today one of the top 3 companies in India.
Currently, 4500 employees are working in the company.
We can contact the company in the following ways.
Website – www.natcopharma.co.in
Contact No – +91-40-2354 7532
Email – investors@natcopharma.co.in
Address – Natco House Road No.2, Banjara Hills Hyderabad-500 034, India
CIN – L24230TG1981PLC003201
Social Platforms – The company is active on LinkedIn & Twitter
Table of Contents
Natco Pharma Limited Share Price
The company has been on the stock market since 2005. This lion, which is between 20 and 25, has started showing growth since 2014. Currently, Natco Pharma Limited’s Share Price in March 2024 is Rs.1015.
Face Value of Sher is 2.00. This means that this lion is split in the future.
The stock is trading at a PE ratio of 14.2.
Natco Pharma Limited Financials
Natco Pharma Limited’s market cap as of March 2024 is Rs 18,187 crore. You will get a 0.94% dividend of profit after buying shares of this company.
The operating Profit Margin of the company is 41.6% which is considered a good OPM.
First, according to the investor’s calculations, the promoter holding in the company should be more than 50 percent, but here the promoter holding is 49.7 percent. The pledged percentage is 0.
The company has reserves of Rs 5,258 crore. Cash Equivalents are 720 crores.
Natco Pharma Limited Business Model
Natco Pharma Limited (NATCO) is a strong pharmaceutical company
The company is particularly focused on R&D.
This company does formulation work in complex pharmaceuticals.
The company has a total of 9 factories and 2 research centers across India. All research centers are located in Telangana
Board of Directors
The company has a pool of talent in their board members. Their expertise helps the company grow in the most competitive market.
All board members are as follows:
- Sri V. C. Nannapaneni (Chairman and Managing Director)
- Sri Rajeev Nannapaneni (Vice Chairman and Chief Executive Officer)
- Sri A.D.M. Chavali (Independent Director)
- Sri T.V. Rao (Independent Director)
- Dr. Leela Digumarti (Independent Director)
- Dr. M.U.R. Naidu (Independent Director)
- Dr. Linga Rao (Director and President, Technical Affairs)
- Dr. Pavan Bhat (Director and Executive Vice President (Technical Operations))
- Ms. Mamatha C. V. Rao (Director)
- Dr. Pavan Bhat (Vice President, Technical Operations)
Executive Team Members
Without executive members, the company can face many challenges in its day-to-day operations. A team of executives is very important to keep the company’s balance sheet positive.
Good team leaders have the potential to generate 10x the growth of the business. After the management team of executives, they are the one kind of asset for the company.
Below, you can check the list of executives of Natco Pharma.
V. C. Nannapaneni – Chairman and Managing Director
Rajeev Nannapaneni – Vice-Chairman and Chief Executive Officer
Prasad P. S. R. K. – Director and Executive Vice President, Corp. Engineering Services
Dr. Linga Rao Donthineni – Director and President, Technical Affairs
Dr. Pavan Ganapati Bhat – Director and Executive Vice President (Technical Operations)
Appa Rao S V V N – Chief Financial Officer
Dr. Pulla Reddy M – Executive Vice President, R&D
Dr. Ramesh Dandala- Executive Vice President, Technology Transfer, Intellectual Property Rights, and Regulatory Affairs (API)
Sadasiva Rao N – Executive Vice President, Corporate Affairs, Legal & Secretarial, Estate
ManagementRajesh Chebiyam – Executive Vice President, Crop Health Sciences
Dr. Gopalakrishnan Vaidyanathan – Senior Vice President, Analytical R&D
Lakshminarayana A – Senior Vice President, HR & OD
Ramakrishna Sridhar Reddy – Senior Vice President, Corporate Q.A.
Srinivas Ch – Senior Vice President, Demand and Supply Planning
Sunil Kotaru – Senior Vice President, Supply Chain Management
S. Raviprakash Reddy – Senior Vice President, Operations
Venkat Rao Tummala – Vice President, Production
Gnanadeva Chalapathy Gudipati – Vice President, Analytical Research and Development
James Rajakumar – Vice President, Marketing and Sales, Domestic
Nadella Malleswara Rao – Vice President, Head of Operations
Kurra Venkata Sreenivasa Babu – Vice President, Operations
Dr. Rampalli Sriram – Vice President, CRD
Sandeep Kumar – Vice President (QA)
Dr. Praveen Chowdary Myneni – Vice President, Medical Affairs & CR
Dr. Gogula Venkata Ramana – Vice President, Drug Development and CR
Dr. Pratima Jain – Vice President, IPR
Barur Praveen Kumar – Vice President, IBD
Amresh Kumar Trivedi – Deputy General Manager, Legal
Venkat Ramesh Ch – Company Secretary and Compliance Office
Natco Pharma Limited Clientele
If we talk about their customers, then they do not provide a list of clients anywhere on the Internet.
As they are working on the formulation of the medicine, they have direct access to hospitals across India and outside India as well.
They specialize or are well-known in the field of oncology medicine.
Technology Which Company Use
As the company is working on the API creation of the medicine, it is a must to keep the infrastructure updated with the latest technology. Ultimately, this will enhance the productivity of the company.
The company has five FDF manufacturing facilities, two API manufacturing facilities, two R&D centers, and two crop health sciences units.
The company has its focus on building maximum in-house formulation capacity. It will help companies create a moat around their business.
Moat of Natco Pharma Limited
As we discussed, the company is trying to build technology to create in-house formulations, which will help it lead the market.
They are also focused on the oncology department, and this makes them dig deep into the focused area.
Natco has a reputation for API manufacturing, and they are quite consistent in their manufacturing. Even in the coronavirus pandemic, they run their operations smoothly. This is the best moat that companies have.
Future of Industry
The current health industry market in India is around 375 billion dollars in 2024. According to research, this market will grow with a 22% compound annual growth rate (CAGR).
As the health industry grows, pharmaceutical companies and API formulation makers will also experience growth. Therefore, the future of Natco Pharma looks promising if the company maintains consistency in the market.
